Skip to main content
. 2024 Jul 12;110(10):6647–6657. doi: 10.1097/JS9.0000000000001813

Figure 4.

Figure 4

Overall survival and recurrence-free survival of 24 patients with hepatocellular carcinoma beyond Milan criteria who received liver transplantation after neoadjuvant immune checkpoint inhibitors in our center.